Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel
Clinical trial NCT00082134 · COMPLETED
Trial details
- NCT number
- NCT00082134
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.